Human clinical trials with schizophrenia

Available for qualified participants. Schizophrenia Clinical Research Trials. We have helped tens of thousands of patients in similar studies. Space in this study is limited. To be considered, please fill out the form or call No cost studies are currently available for qualified participants. No health insurance required. Compensation for time and travel TBD. Lives with schizophrenia. Enroll Now. How did you hear about us?

You can call, email, or text me about selected or relevant future studies. This field is for validation purposes and should be left unchanged.

Refer a Friend. Board Certified Physicians Your safety is our greatest concern. Frequently asked questions. View all FAQs. What is a CenExel Center of Excellence? How do clinical trials work? How safe are clinical studies? Call Now To Enroll. The Task Force is charged with continuous monitoring of the pandemic and providing guidance and communication. Riley Hospital for Children, Indiana University. Tulane University Health Science Center.

UCI Medical Center. Connecticut Mental Health Center. VA Connecticut Healthcare System. San Francisco Veterans Medical Center. IU Biostatistics. Prevention and Recovery Center for Early Psychosis.

Atlanta Center for Medical Research. Renew Behavioral Health. Johns Hopkins Hospital. The University of California, San Diego. Northwestern University. University of Colorado Anschutz Medical Campus. Collaborative Neuroscience Network, Inc. Neurobehavioral Research, Inc. Premier Clinical Research Institute. University of California at San Francisco. ProScience Research Group. Louisiana Clinical Research. New York University School of Medicine.

Augusta University. Stanford University. Alkermes Study Site. Alkermes Investigational Site. New York State Psychiatric Institute. New Hope Clinical Research. Harmonex Neuroscience Research. Cutting Edge Research Group. Study Population: participants The study will include research subjects with schizophrenia. Study Design: There are several phases to this protocol. Outcome Measures: Parameters under investigation include traits that are candidate phenotypes for genetic studies and state-dependent aspects of brain function.

MedlinePlus related topics: Schizophrenia. FDA Resources. Outcome Measures. Primary Outcome Measures : To explore the neuropsychological response in research subjects withschizophrenia under placebo conditions without the confounding effect of antipsychotics. Eligibility Criteria. Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Because of the long half-life of depot medications such as paliperidone palmitate Invega Sustenna , applicants to our program will be excluded if they are currently receiving depot medications monthly.

However, applicants may decide to switch from depot to oral medications on their own, in conjunction with their personal physician, before coming to the program. This is not part of research and we do not participate in this decision. A sufficient washout period based on the particular long-acting injectable medication s elimination half-life will be required in order for prospective participants to be eligible.

Most such medications require a 6-month washout period, but some with shorter elimination half-lives, such as risperidone powder Risperdal Consta , only require 3 months. Subjects may complete the last 3 months of washout in the inpatient unit while being evaluated during the Screening Evaluation and Stabilization Phase. Major medical illness. Research subjects identified as having major medical problems other than their primary neuropsychiatric disorder will be excluded from admission. Applicants judged to be unsuitable for medication free studies will also be excluded.

Possible reasons for exclusion include prior history of dangerousness to self or others, particularly when off medication. Applicants who are pregnant are excluded from this study. Volunteers who are found to be pregnant after testing will be terminated from study and referred to an OB-GYN for follow up care. Infection with syphilis, hepatitis, or HIV. Cumulative lifetime history of any excepting nicotine-related DSM5-defined mild substance use disorder or any DSM-IV-defined substance abuse , either in excess of 5 years total or not in remission for at least 6 months.

Lack of capacity to provide consent. Exclusion Criteria for Previously Enrolled Research Subjects No longer satisfying the above inclusion criteria or meeting any of the above exclusion criteria Inability to safely participate in planned research e. Contacts and Locations. Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials. More Information. Epub May